Sapience Therapeutics Inc.

Changing the tide to achieve the unachievable

Harrison, United States · Founded 2020 · $4.0M raised

Headquarters
Harrison, New York
Employees
1–10
Founded
2020
Business Model
B2G
Total Funding
$4.0M
Last Round
$632K GrantJan 2024
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Sapience Therapeutics is a clinical-stage oncology company developing precision peptide therapeutics using its SPEARs™ and SPARCs™ platforms that target intracellular and extracellular protein-protein interactions. Its lead programs, lucicebtide (ST101) and ST316, are in Phase 2 trials for glioblastoma, melanoma, and colorectal cancer.

Summary

Sapience Therapeutics Inc. is a Biotech company based in Harrison, United States, founded in 2020. It has raised $4.0M in total across 5 rounds, most recently a $632K Grant round in Jan 2024. Investors include National Cancer Institute and National Institute of Allergy and Infectious Diseases.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantJan 2024
$632K

Sign up to see all 5 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sapience Therapeutics Inc. on Indexed.vc
<a href="https://indexed.vc/companies/sapience-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/sapience-therapeutics-inc" alt="Sapience Therapeutics Inc. on Indexed.vc" width="260" height="76" /></a>